LPC Matrix Enhances Fat Absorption in Malabsorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for fat malabsorption, such as pancreatic enzyme replacement therapy, do not consistently restore normal fat absorption levels in individuals with exocrine pancreatic insufficiency or bile acid deficiency, leading to persistent symptoms like gastrointestinal pain and diarrhea, and can exacerbate symptoms with increased dietary fat consumption.
Innovation Solution
A matrix comprising lysophosphatidylcholine (LPC) is administered to enhance fat absorption in the digestive tract, independent of pancreatic lipase and bile acid function, by forming micelles that facilitate the absorption of dietary fats and fat-soluble vitamins, potentially combined with food or beverages to improve nutritional uptake.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pancreatic enzyme replacement therapy is used to treat fat malabsorption, then fat absorption is improved to some extent, but it does not consistently restore normal fat absorption levels and may exacerbate gastrointestinal symptoms
Solution Approach 1:
The patent introduces a novel intermediary substance (specific enzyme formulation or adjuvant) that mediates between the pancreatic enzymes and the malabsorbed fats, improving the efficiency of fat digestion and absorption while reducing gastrointestinal side effects. This intermediary enhances the interaction between lipases and dietary fats, enabling more reliable restoration of fat absorption without exacerbating GI symptoms.
Solution Approach 2:
The patent modifies key parameters of the enzyme replacement therapy, such as enzyme concentration, particle size, release rate, or formulation composition, to optimize fat absorption restoration. By adjusting these parameters, the therapy achieves more consistent normalization of fat absorption while minimizing gastrointestinal discomfort and diarrhea associated with conventional dosing.
2Quantity of substance
If dietary fat consumption is increased to improve nutritional status, then weight and growth are enhanced, but gastrointestinal symptoms are exacerbated
Solution Approach 1:
The patent employs an intermediary substance that facilitates the digestion and absorption of increased dietary fat intake. This intermediary enables patients to consume higher quantities of dietary fat for improved nutrition and weight gain while preventing the exacerbation of gastrointestinal symptoms that would normally occur with increased fat consumption.
Solution Approach 2:
The patent enables the digestive system to self-adjust and efficiently process increased dietary fat intake through enhanced enzyme activity or improved micelle formation. The modified therapy allows the body's natural digestive mechanisms to handle higher fat loads without overwhelming the system, thus improving nutritional status while avoiding GI symptom exacerbation.
3Productivity
If conventional fat absorption methods are used in severe malabsorption cases, then some fat absorption occurs, but absorption levels remain insufficient to support optimal weight status and healthy growth
Solution Approach 1:
The patent employs a composite formulation combining multiple enzymatic components, adjuvants, or delivery vehicle materials to enhance fat absorption efficiency. This composite approach creates a synergistic effect that significantly improves the productivity of fat absorption, enabling sufficient nutrient uptake to support optimal weight status and healthy growth even in severe malabsorption cases where conventional single-enzyme therapies fail.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The LPC matrix significantly increases dietary fat absorption by up to 10-fold, enhancing the absorption of essential fatty acids and fat-soluble vitamins, improving weight status and growth in individuals with impaired fat absorption, regardless of lipase activity or bile acid levels.
Implementation Method 1
LPC may be in the form of micelles or micelle-like structures... LPC and/or LPC micelles or micelle-like structures enhance fat absorption in the digestive tract
Data Source
AI summary
Provided herein are methods of increasing absorption of dietary fat and fat-soluble nutrients in individuals using a matrix comprising lysophosphatidylcholine (LPC).